Product Program year 2020 Source: CMS Open Payments

CD cobas Reagents

Device Centralized Diagnostics

Open in the dashboard

General payments

$507,451

767 payments

Research payments

$12,121,583

272 payments

Through program year 2020, $507,451 in general payments and $12,121,583 in research payments were reported against CD cobas Reagents (Centralized Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $182,183 182
2020 Research $3,581,208 107
2019 General $325,268 585
2019 Research $8,540,375 165

Breakdown

Who paid General payments · program years 2019–2020
  1. Roche Diagnostics Corporation $466,288 755 payments
  2. Roche Diagnostics Operations, Inc. $38,363 11 payments
  3. Roche Diagnostics International Ltd $2,800 1 payment
Top recipients General payments · program year 2020
  1. Sarosh Rana Maternal & Fetal Medicine · Chicago, IL $34,820 19% · 11 payments
  2. Erik Alexander Endocrinology, Diabetes & Metabolism · Boston, MA $27,305 15% · 6 payments
  3. Jimmy Espinoza Maternal & Fetal Medicine · Houston, TX $21,663 12% · 13 payments
  4. Douglas Woelkers Obstetrics · La Jolla, CA $13,789 8% · 9 payments
  5. Maria Martin Lopes Cresskill, NJ $5,250 3% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Maternal & Fetal Medicine Obstetrics & Gynecology $74,592 44% · 8 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $30,205 18% · 2 practitioners
  3. Emergency Medicine $18,456 11% · 13 practitioners
  4. Obstetrics & Gynecology $17,932 11% · 48 practitioners
  5. Obstetrics Obstetrics & Gynecology $13,980 8% · 6 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Massachusetts $37,563 21% · 5 recipients
  2. Illinois $34,878 19% · 5 recipients
  3. Texas $26,491 15% · 4 recipients
  4. California $21,442 12% · 29 recipients
  5. Indiana $12,367 7% · 8 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

767 general · 272 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record